Skip to content

Author

Qiaohua Yan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Repurposing simeprevir uncovers a druggable KPNB1-p65-BCL2 survival axis in cancer.

This study elucidates a therapeutically targetable KPNB1-p65-Bcl-2 survival axis in multiple cancers and establishes a foundation for developing next-generation KPNB1 inhibitors.

Cong Li, Qiaohua Yan, Muhammad Muddasar Saeed et al. · 0 citations